Eisai will request reconsideration of preliminary determination for lecanemab in Australia By Investing.com
STOCKHOLM, Oct. 16, 2024 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA…
“LEQEMBI” (Lecanemab) Permitted for the Therapy of Alzheimer’s Illness within the United Arab Emirates By Investing.com
TOKYO and CAMBRIDGE, Mass., Aug 14, 2024 - (JCN Newswire) - -…
